DocShifter is Moving

DocShifter is Moving to Grow

Move To Grow

Exciting times ahead for the DocShifter team, with the upcoming move to our new office! 

Some people have asked us: ‘Why are you moving?’. On one side reasons are purely practical, on the other they are related to our growth, so now is a great time to share these with you.

Read more

Advanced Rendering - What is Advanced Rendering ? Part II

3 Guiding principles when implementing Advanced Rendering in Life Sciences

In our previous post, we introduced our understanding of what advanced rendering is. Why is  this more than just having the right technology in place? The first step is to make an inventory throughout the enterprise of all rendering processes in place today. This is crucial to evaluate the as-is-situation. Subsequently, we share 3 guiding principles on how that existing process can be improved.

1. Think about the entire document life cycle

Advanced rendering is a lot more than just producing a high quality technically compliant output document right before the submission. When we introduce advanced rendering in the lifecycle of the document, then, in that moment, possibilities become endless.

Read more

Advanced rendering. Compliant rendering. High fidelity or hi-fi document rendering. There are a lot of terms out there, but what do they really mean? How can they make your life easier within Life Sciences and why should you consider having a closer look?

What does Advanced Rendering mean?

Advanced rendering. Compliant rendering. High fidelity or hi-fi document rendering. There are a lot of terms out there, but what do they really mean? How can they make your life easier within Life Sciences and why should you consider having a closer look?

When you’re working in a tightly-regulated industry, like Life Sciences, compliance comes first. At the same time, business needs are growing, and there is huge pressure to get to market fast. So organizing your processes in the most efficient way is key. Advanced rendering plays a big role here.

“Our ambition with this series of blogs is to

broaden the spectrum, and demonstrate that

advanced rendering is more than just excellent technology.”

Read more

Key Disruptors Life Sciences

What are the key disruptors for Life Sciences?

Every industry goes through changes over time and the Life Sciences industry is no exception. But not every change is significant. With so many buzzwords and jargon being thrown around, sometimes it’s hard to wade through the noise and get to the heart of it all.

Read more

Compliant Rendering Tool

6 good reasons why leading Life Sciences companies are rethinking their Document Rendering Solution

We have been converting divergent documents into a unified format such as PDF for many years now.

In knowledge-driven industries such as Life Sciences in particular, the need for standardization is highly motivated by the regulators. The introduction of the electronic Common Technical Document (eCTD) has accelerated the move from paper to electronic formats. And the International Conference on Harmonization (ICH) has further solidified this drive in its recent implementation guides for Regulated Product Submissions (RPS). Read more

Correspondence Tracking

5 steps to reduce risks from your current correspondence tracking solution

Life Sciences organizations face many challenges when tracking all of the communication that takes place between themselves and other external organizations and health authorities that they deal with on a regular basis. An essential part of any complete Regulatory Information Management (RIM) platform is the ability to plan and track all regulatory activities that an organization needs to undertake. These activities are often initiated by a request that is sent from a health authority for more information, and it is critical that these requests are traceable alongside the tracked regulatory activities in the RIM platform. Read more

Image: Ede Faludi - CEO DACHS with Geert van Peteghem - CEO DocShifter

DACHS Biosciences and DocShifter Partner Up to Help Life Sciences Companies Deal With the Growing Challenges Around Advanced Document Conversion

We are proud to announce our new partnership with DACHS to meet the growing needs for document conversion & enrichment in the Life Sciences industry.  The advanced content conversion capabilities of DocShifter combined with the expertise of DACHS in document management for pharmaceutical companies make a powerful strategic alliance.  Read more

About us - Trusted Partners

Generis and DocShifter Partner to Provide Compliant Content for Life Sciences

DocShifter proudly announces its exciting new partnership with Generis Knowledge Management Inc. to provide industry-leading rendition handling as part of their CARA toolsuite. The advanced content conversion abilities of DocShifter, together with the functionality in CARA and the resulting application will provide complete compliance functionality for regulated content management use cases, especially for Life Sciences.

Serving the world’s top Life Sciences companies

“There are various regulatory requirements that our clients face to provide content in a compliant set of formats, with the features and functionality of CARA on top”, said James Kelleher, CEO at Generis. “Our integration with DocShifter enables customers to ensure that content is managed to these requirements, with a wide range of integrations that CARA also offers to other applications specifically in the Life Sciences industry.”

Read more

Digital Archiving - Long Term Digital Preservation

Why and how to preserve your digital archive?

The volume of digital information is increasing at warp-time speed. Whether created as a result of the digitising of non-digital collections, as a digital publication or artwork, or as an inherent part of the day-to-day business of an organisation or individual, more and more information is being created digitally and the pace at which it is being created is accelerating. Read more

Exit Brexit - Our Key Takeaways from TOPRA 2018

Exit Brexit? Our 5 takeaways from TOPRA 2018

Our VP of Life Sciences, Paul Ireland, was at the TOPRA 2018 Symposium in Stockholm, Sweden from October 1st – 3rd to hear and discuss the latest news and initiatives within the pharmaceutical industry together with Life Sciences regulatory professionals from Europe and around the world. Due to the wide-ranging ongoing initiatives within the regulatory space across all divisions of Life Sciences, the conference was split into multiple tracks:

  1. Human medicines
  2. Medical devices
  3. Veterinary medicines

From the initial introduction by Lynda Wight from TOPRA, it was clear that the topic of Brexit would have a role in many of the discussions during the three day agenda. Read more